Extension of Time to File SOU

PTO- 1581

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1581

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: TULVEGIO RIVOCERANIB (stylized and/or with design, see http://uspto.report/TM/88620374/mark.png)
SERIAL NUMBER: 88620374

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Elevar Therapeutics, Inc., having an address of
      2825 East Cottonwood Parkway, Suite 180
      Salt Lake City, Utah 84121
      United States
      Phone: 8012555335
      Email: XXXX
Proposed: Elevar Therapeutics, Inc., having an address of
      2825 East Cottonwood Parkway, Suite 180
      Salt Lake City, Utah 84121
      United States
      Phone: 8012555335
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 08/17/2021.

For International Class 005:
Current identification: Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 035:
Current identification: Marketing in the field of cancer treatments containing rivoceranib

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Development of therapeutics for the treatment of cancer containing rivoceranib

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Grant R. Clayton
      PRIMARY EMAIL FOR CORRESPONDENCE: docketclerk@clayhow.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): gclayton@clayhow.com

Correspondence Information (proposed):
      Grant R. Clayton
      PRIMARY EMAIL FOR CORRESPONDENCE: docketclerk@clayhow.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): gclayton@clayhow.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $375 will be submitted with the form, representing payment for 3 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Grant R. Clayton/      Date Signed: 02/17/2022
Signatory's Name: Grant R. Clayton
Signatory's Position: Attorney of Record, Utah Bar Member
Signatory's Phone: 801-255-5335
Signature method: Signed directly within the form

PAYMENT: 88620374
PAYMENT DATE: 02/17/2022

Serial Number: 88620374
Internet Transmission Date: Thu Feb 17 16:49:20 ET 2022
TEAS Stamp: USPTO/ESU-XX.XX.XX.XX-202202171649208029
51-88620374-8008cb841f9121a70ad9ea1a33ec
9c9b9742da0be7bfdcb22d3c44a286366b46ffe-
CC-49171822-20220217164435254314